What Is Haploidentical Bone Marrow Transplant (Haplo BMT) & Why Is It a Lifesaver for Children?

When a child is diagnosed with a life-threatening blood disorder such as leukaemia, aplastic anaemia, thalassemia, or certain immune deficiencies, a bone marrow transplant may offer the best chance of long-term survival. However, many families face another major hurdle: finding a fully matched donor.

Only about 25–30% of patients have a perfectly matched sibling donor. The remaining children often need an unrelated donor, which may not be available in time or may never be found, especially in countries where donor registries are limited.

This is where haploidentical bone marrow transplantation (Haplo BMT) has changed the landscape of pediatric blood disorder treatment.

Instead of waiting months for a perfect donor, doctors can use a half-matched family member, usually a parent, sibling, or child, making life-saving treatment possible for many more patients.

A haploidentical bone marrow transplant is a type of stem cell transplant in which the donor shares approximately 50% of the patient’s HLA tissue markers. Most commonly, one of the child’s parents becomes the donor. Advances in transplant techniques have made haploidentical BMT a safe and effective option when a fully matched donor is unavailable.

Understanding Human Leukocyte Antigen (HLA)

Before understanding Haplo BMT, it’s important to know why matching matters.

Every person’s immune system carries proteins called Human Leukocyte Antigens (HLA). These markers help the immune system distinguish between the body’s own cells and foreign cells.

During a bone marrow transplant:

• Better HLA matching lowers complications.
• Poor matching increases the risk of graft rejection.
• It also raises the chance of graft-versus-host disease (GVHD).

Traditionally, doctors preferred a 10/10 HLA-matched donor but today, improvements in transplant medicine have  expanded donor options.

What Does “Haploidentical” Mean?

“Haplo” means half.

A haploidentical donor shares half of the HLA markers with the patient.

Most children naturally share half of their HLA genes with:

• Mother
• Father
• Brother
• Sister

As almost every child has at least one parent who is a half-match, donor availability increases .

Why Is Haploidentical BMT Considered a Lifesaver?

1. Almost Every Patient Has a Donor

One of the biggest advantages is donor availability.

Instead of waiting for:

• National donor registries
• International donor searches
• Months of uncertainty

Doctors can often identify a suitable family donor within days.

This is especially important in aggressive diseases like acute leukemia, where delaying treatment may reduce the chances of success.

2. Faster Treatment

Time is critical in many blood disorders.

A quicker transplant means:

• Better disease control
• Lower risk of relapse before transplant
• Improved survival in selected patients

3. Better Access for Indian Families

Finding unrelated donors is often more challenging for Indian patients due to the relatively smaller donor pool in registries.

Haploidentical transplantation has significantly improved access to curative treatment by allowing eligible family members to serve as donors.

4. Comparable Outcomes

With modern transplant protocols, carefully selected patients undergoing haploidentical BMT can achieve outcomes equal to matched donor transplants in many situations.

Advances include:

• Better GVHD prevention
• Improved infection control
• Enhanced supportive care

Results depend on factors such as the child’s diagnosis, disease stage, overall health, donor suitability, and the transplant center’s expertise.

Which Diseases Can Be Treated with Haploidentical BMT?

A haploidentical transplant may be considered for children with:

Blood Cancers

• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)
• Chronic Myeloid Leukemia (selected cases)
• Lymphoma

Read more – Blood Cancer Treatment in Delhi

Non-Cancerous Blood Disorders

• Thalassemia Major
• Severe Aplastic Anemia
• Sickle Cell Disease

Immune Disorders

• Severe Combined Immunodeficiency (SCID)
• Wiskott-Aldrich Syndrome
• Chronic Granulomatous Disease

Metabolic Disorders

Certain inherited metabolic conditions may also be treated with stem cell transplantation.

The decision depends on a detailed evaluation by a pediatric hemato-oncologist and transplant team.

Who Can Donate?

Potential haploidentical donors include:

• Mother
• Father
• Brother
• Sister
• Adult child (for adult patients)

The donor undergoes comprehensive testing to assess:

• HLA compatibility
• General health
• Infectious disease screening
• Organ function

How Is the Procedure Performed?

The transplant journey generally involves:

Step 1: Evaluation

Doctors assess the child’s condition, disease status, and donor suitability.

Step 2: Conditioning Therapy

Chemotherapy, with or without radiation in selected cases, prepares the body to receive healthy stem cells.

Step 3: Stem Cell Collection

Stem cells are collected from the donor, usually from the bloodstream after medication stimulates stem cell production. In some situations, bone marrow may be used.

Step 4: Stem Cell Infusion

The healthy stem cells are infused into the child’s bloodstream, similar to a blood transfusion.

Step 5: Engraftment

Over the next few weeks, the transplanted cells begin producing healthy blood cells.

For Detailed Peocedure click- Haploidentical BMT

What Are the Benefits of Haploidentical BMT?

• Nearly every patient has a potential donor.
• Reduces delays in treatment.
• Eliminates long donor searches in many cases.
• Makes transplantation accessible to more families.
• Can offer curative treatment for several blood disorders.
• Modern protocols have improved safety and outcomes.

Are There Any Risks of Haplo BMT ?

Like all bone marrow transplants, Haplo BMT carries potential risks, including:

• Graft-versus-host disease (GVHD)
• Infections
• Delayed immune recovery
• Graft failure
• Organ-related complications

These risks are managed through careful donor selection, medications, close monitoring, and specialized supportive care.

Final Thoughts

The inability to find a fully matched donor no longer means a child has to miss the opportunity for a potentially curative bone marrow transplant. With modern haploidentical bone marrow transplantation, parents and other close family members can often become life-saving donors, making treatment possible for children who previously had limited options.

If your child has been advised to undergo a bone marrow transplant and a matched donor is not available, discussing the possibility of a haploidentical BMT with an experienced pediatric hemato-oncologist can help you understand whether this approach is suitable for your child’s condition.

For expert evaluation of childhood blood cancers and haploidentical BMT , you may consult Dr. Satyendra Katewa, a trusted paediatric haemato-oncologist in Delhi.